Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China
Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP...
Saved in:
Published in | BMC microbiology Vol. 21; no. 1; pp. 109 - 8 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
11.04.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination.
A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (bla
), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation.
Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed. |
---|---|
AbstractList | Background Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. Results A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (bla.sub.KPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Conclusions Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed. Keywords: Carbapenem resistance, Klebsiella pneumoniae, Fosfomycin, fosA3 Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (bla.sub.KPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed. Abstract Background Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. Results A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (bla KPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Conclusions Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed. Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (bla ), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed. Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination.BACKGROUNDFosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination.A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (blaKPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation.RESULTSA total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (blaKPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation.Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed.CONCLUSIONSAlthough the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed. Background Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. Results A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (blaKPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Conclusions Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed. |
ArticleNumber | 109 |
Audience | Academic |
Author | Li, Jun Zou, Mingxiang Min, Changhang Wang, Haichen Dou, Qingya Yu, Ting Hu, Yongmei |
Author_xml | – sequence: 1 givenname: Haichen surname: Wang fullname: Wang, Haichen – sequence: 2 givenname: Changhang surname: Min fullname: Min, Changhang – sequence: 3 givenname: Jun surname: Li fullname: Li, Jun – sequence: 4 givenname: Ting surname: Yu fullname: Yu, Ting – sequence: 5 givenname: Yongmei surname: Hu fullname: Hu, Yongmei – sequence: 6 givenname: Qingya surname: Dou fullname: Dou, Qingya – sequence: 7 givenname: Mingxiang surname: Zou fullname: Zou, Mingxiang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33838639$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ktlu1DAUhiNURBd4AS6QJW7gIsXbeLlBqkYsIyohsVxbJ44z4yqxBzsByuPwpDidtnQqhKIojvP9_zk--Y-rgxCDq6qnBJ8SosSrTKgSosaUzLdY1PJBdUS4JDUlCh_cWR9WxzlfYEykYvJRdciYYkowfVT9Xm4ggR1d8r9g9DGg2KEu5i4Ol9YHlFz2eYRgHYLQoiH2zk49JOS2vnWDj31cXyIYYlgjC6mBrQtuqG9kI_rQuyZ71_eAtsFNBfTgUB4T-JBRl-KAxh8RlQZGD-kSbWLe-hH6jEr15cYHeFw97Mq7e3L9PKm-vn3zZfm-Pv_4brU8O6_tQsux1g3ljOCFZtYBA67JAlTHXMudYFh2TFMKCgtLMFMcJAVooRHENoI3srXspFrtfNsIF2ab_FD6MRG8udqIaW2gNGl7ZzpJG9tK4haWc65b0FxroltlsYNSuHi93nltp2ZwrXWhHLjfM93_EvzGrON3ozCTStNi8OLaIMVvk8ujGXy28xiDi1M2dFEioDkVrKDP76EXcUqhjGqmOJVCYPqXWkM5gA9dLHXtbGrOhCBMEcp5oU7_QZVr_te2xK_zZX9P8HJPUJjR_RzXMOVsVp8_7bPP7g7ldho3aSwA3QE2xZyT624Rgs0cebOLvClxN1eRN7KI1D2RLfmZozxnrP-f9A9jAAfM |
CitedBy_id | crossref_primary_10_1016_j_micres_2024_127701 crossref_primary_10_3389_fcimb_2024_1447933 crossref_primary_10_3390_ph15081011 crossref_primary_10_1186_s12941_023_00560_8 crossref_primary_10_1016_j_scitotenv_2022_153928 crossref_primary_10_1016_j_micpath_2025_107399 crossref_primary_10_1016_j_idairyj_2024_106068 crossref_primary_10_1136_archdischild_2021_322483 crossref_primary_10_1155_2022_2615753 crossref_primary_10_1016_j_micpath_2024_106728 crossref_primary_10_1016_j_scitotenv_2021_149859 crossref_primary_10_1128_spectrum_00095_23 |
Cites_doi | 10.1016/j.ijantimicag.2016.02.001 10.1128/AAC.01834-09 10.1093/jac/dkq347 10.1016/j.ijantimicag.2009.11.011 10.1089/fpd.2016.2230 10.1016/j.ijantimicag.2020.106226 10.1016/j.ijantimicag.2016.08.013 10.1128/AAC.03061-14 10.1186/s12941-016-0148-y 10.1128/AAC.06122-11 10.1093/cid/ciq257 10.2147/IDR.S209877 10.1093/jac/dks192 10.1111/j.1469-0691.2011.03636.x 10.1099/jmm.0.000874 10.1016/j.diagmicrobio.2010.12.002 10.1089/mdr.2018.0137 10.1110/ps.03585004 10.1128/AAC.00734-08 10.1128/AAC.05104-11 10.1016/j.bpj.2018.12.002 10.1016/j.mimet.2005.03.018 10.1016/j.ijantimicag.2014.08.010 10.4103/0366-6999.189049 10.1016/j.jgar.2019.12.019 10.2147/IJGM.S214305 10.1099/jmm.0.000399 10.1099/jmm.0.062653-0 10.1093/jac/dkr466 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | AAYXX CITATION NPM ISR 3V. 7QL 7T7 7U9 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s12866-021-02165-7 |
DatabaseName | CrossRef PubMed Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ: Directory of Open Access Journal (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology Statistics |
EISSN | 1471-2180 |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_f72bcd71e5c4449da949919d8c0ea915 PMC8037892 A661381244 33838639 10_1186_s12866_021_02165_7 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IGS IHR INH INR ISR ITC KQ8 LK5 LK8 M1P M48 M7P M7R MM. M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB ~02 -A0 3V. ACRMQ ADINQ AGJBV C24 NPM PMFND 7QL 7T7 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c597t-9b24310593cea3a4915a8f3ed4e6307f3922a806c10384a72aadab61cb64b7dc3 |
IEDL.DBID | DOA |
ISSN | 1471-2180 |
IngestDate | Wed Aug 27 01:30:06 EDT 2025 Thu Aug 21 14:12:04 EDT 2025 Fri Jul 11 04:15:35 EDT 2025 Fri Jul 25 19:15:15 EDT 2025 Tue Jun 17 21:08:17 EDT 2025 Tue Jun 10 20:28:03 EDT 2025 Fri Jun 27 05:00:01 EDT 2025 Wed Feb 19 02:27:54 EST 2025 Thu Apr 24 23:09:25 EDT 2025 Tue Jul 01 04:31:36 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Carbapenem resistance fosA3 Klebsiella pneumoniae Fosfomycin |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c597t-9b24310593cea3a4915a8f3ed4e6307f3922a806c10384a72aadab61cb64b7dc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doaj.org/article/f72bcd71e5c4449da949919d8c0ea915 |
PMID | 33838639 |
PQID | 2514276602 |
PQPubID | 42585 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f72bcd71e5c4449da949919d8c0ea915 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8037892 proquest_miscellaneous_2511894263 proquest_journals_2514276602 gale_infotracmisc_A661381244 gale_infotracacademiconefile_A661381244 gale_incontextgauss_ISR_A661381244 pubmed_primary_33838639 crossref_primary_10_1186_s12866_021_02165_7 crossref_citationtrail_10_1186_s12866_021_02165_7 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-04-11 |
PublicationDateYYYYMMDD | 2021-04-11 |
PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC microbiology |
PublicationTitleAlternate | BMC Microbiol |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | CR Lee (2165_CR21) 2016; 7 2165_CR22 DE Karageorgopoulos (2165_CR3) 2012; 67 S Takahata (2165_CR8) 2010; 35 PL Ho (2165_CR24) 2013; 62 R Raz (2165_CR2) 2012; 18 J Li (2165_CR27) 2016; 15 Y Fu (2165_CR31) 2012; 67 J Reyes (2165_CR1) 2019; 12 DJ Wolter (2165_CR26) 2009; 53 K Gupta (2165_CR4) 2011; 52 S Pakhomova (2165_CR9) 2004; 13 W Jiang (2165_CR15) 2017; 14 G Li (2165_CR18) 2015; 59 J Li (2165_CR20) 2016; 129 L Poirel (2165_CR25) 2011; 70 L Huang (2165_CR13) 2021; 57 E Rios (2165_CR28) 2017; 66 KZ Vardakas (2165_CR5) 2016; 47 VK Golla (2165_CR7) 2019; 116 J Wachino (2165_CR14) 2010; 54 L Villa (2165_CR16) 2010; 65 A Carattoli (2165_CR30) 2005; 63 Y Jiang (2165_CR17) 2015; 45 A Couce (2165_CR6) 2012; 56 P Liu (2165_CR12) 2020; 22 M Aghamali (2165_CR10) 2019; 68 PL Lu (2165_CR19) 2016; 48 YM Zhong (2165_CR29) 2019; 12 J Hou (2165_CR23) 2012; 56 J Chen (2165_CR11) 2019; 25 |
References_xml | – volume: 47 start-page: 269 issue: 4 year: 2016 ident: 2165_CR5 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2016.02.001 – volume: 54 start-page: 3061 issue: 7 year: 2010 ident: 2165_CR14 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01834-09 – volume: 65 start-page: 2518 issue: 12 year: 2010 ident: 2165_CR16 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkq347 – volume: 35 start-page: 333 issue: 4 year: 2010 ident: 2165_CR8 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2009.11.011 – volume: 14 start-page: 210 issue: 4 year: 2017 ident: 2165_CR15 publication-title: Foodborne Pathog Dis doi: 10.1089/fpd.2016.2230 – volume: 57 start-page: 106226 issue: 1 year: 2021 ident: 2165_CR13 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2020.106226 – volume: 48 start-page: 564 issue: 5 year: 2016 ident: 2165_CR19 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2016.08.013 – volume: 7 start-page: 895 year: 2016 ident: 2165_CR21 publication-title: Front Microbiol – volume: 59 start-page: 338 issue: 1 year: 2015 ident: 2165_CR18 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.03061-14 – volume: 15 start-page: 35 issue: 1 year: 2016 ident: 2165_CR27 publication-title: Ann Clin Microbiol Antimicrob doi: 10.1186/s12941-016-0148-y – volume: 56 start-page: 2767 issue: 5 year: 2012 ident: 2165_CR6 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.06122-11 – volume: 52 start-page: e103 issue: 5 year: 2011 ident: 2165_CR4 publication-title: Clin Infect Dis doi: 10.1093/cid/ciq257 – volume: 12 start-page: 2069 year: 2019 ident: 2165_CR29 publication-title: Infect Drug Resist doi: 10.2147/IDR.S209877 – volume: 67 start-page: 2114 issue: 9 year: 2012 ident: 2165_CR31 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dks192 – volume: 18 start-page: 4 issue: 1 year: 2012 ident: 2165_CR2 publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2011.03636.x – ident: 2165_CR22 – volume: 68 start-page: 11 issue: 1 year: 2019 ident: 2165_CR10 publication-title: J Med Microbiol doi: 10.1099/jmm.0.000874 – volume: 70 start-page: 119 issue: 1 year: 2011 ident: 2165_CR25 publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2010.12.002 – volume: 25 start-page: 251 issue: 2 year: 2019 ident: 2165_CR11 publication-title: Microb Drug Resist doi: 10.1089/mdr.2018.0137 – volume: 13 start-page: 1260 issue: 5 year: 2004 ident: 2165_CR9 publication-title: Protein Sci doi: 10.1110/ps.03585004 – volume: 53 start-page: 557 issue: 2 year: 2009 ident: 2165_CR26 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00734-08 – volume: 56 start-page: 2135 issue: 4 year: 2012 ident: 2165_CR23 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.05104-11 – volume: 116 start-page: 258 issue: 2 year: 2019 ident: 2165_CR7 publication-title: Biophys J doi: 10.1016/j.bpj.2018.12.002 – volume: 63 start-page: 219 issue: 3 year: 2005 ident: 2165_CR30 publication-title: J Microbiol Methods doi: 10.1016/j.mimet.2005.03.018 – volume: 45 start-page: 66 issue: 1 year: 2015 ident: 2165_CR17 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2014.08.010 – volume: 129 start-page: 2033 issue: 17 year: 2016 ident: 2165_CR20 publication-title: Chin Med J doi: 10.4103/0366-6999.189049 – volume: 22 start-page: 238 year: 2020 ident: 2165_CR12 publication-title: J Glob Antimicrob Resist doi: 10.1016/j.jgar.2019.12.019 – volume: 12 start-page: 437 year: 2019 ident: 2165_CR1 publication-title: Int J Gen Med doi: 10.2147/IJGM.S214305 – volume: 66 start-page: 169 issue: 2 year: 2017 ident: 2165_CR28 publication-title: J Med Microbiol doi: 10.1099/jmm.0.000399 – volume: 62 start-page: 1707 issue: Pt 11 year: 2013 ident: 2165_CR24 publication-title: J Med Microbiol doi: 10.1099/jmm.0.062653-0 – volume: 67 start-page: 255 issue: 2 year: 2012 ident: 2165_CR3 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkr466 |
SSID | ssj0017837 |
Score | 2.3704143 |
Snippet | Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella... Background Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant... Abstract Background Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 109 |
SubjectTerms | Amino acids Antibiotics Bacterial infections Binding sites Biosynthesis Carbapenem resistance Conjugation Drug resistance in microorganisms Drug therapy E coli Enzymes Epidemiology fosA3 Fosfomycin Genes Genetic aspects Genomic analysis Identification and classification Infections Klebsiella Klebsiella infections Klebsiella pneumoniae Molecular modelling Multidrug resistance Physiological aspects Plasmids Statistics Strains (organisms) |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4t1AQQYhcUBRY8drJydUKqoCggNQaW_WxHHalbrJstkV2r_DL2XGebQRUg97WY-168zbmfmGsbc5Sk0pIYudTHWsQKg4h8THKCroDxPpAKg5-dt3fXqmvsxn8_7Cre3LKgebGAx12Ti6Iz9EP6yk0TqRH1a_Y5oaRW9X-xEat9kdgi6jki4zHxMuYTD7GhplMn3Yoi3WVHIr6KNnsZk4o4DZ_79lvuaapmWT1_zQyQN2vw8g-VHH8Yfslq8fsbvdSMndY_b3eERg7hoseVPxqsHYdLlzi5pjdk0RI7KaQ13y5TAdl_urUbE7HkYQcUfvIlZoDJfxsG3Dv176ol1QzRRf1X6LhAvwvA2jJlpO3Sp886fhVGqwgPWOX_SDSVqOvx6mdT9hZyeffh2fxv0chthhurGJ80JimEGz_5yHFFQuZpBVqS-V12giKgyxkNuJdgS2rsBIgBIKLVyhVWFKlz5le3VT-33GMRkXzkkpKgzdjPQA2gM1z85Al9rIiImBIdb1IOV0gEsbkpVM246JFhloAxOtidj7cc-qg-i4kfoj8XmkJHjt8EWzPre9ttrKyMKVRviZU0rlJRCEj8jLzCUe8PgRe0NSYglAo6YKnXPYtq39_POHPcKAJw1RU8Te9URVg2dw0Dc84JMgzK0J5cGEEjXcTZcHYbS9hWntlT5E7PW4TDtJAmrfbAONyHKC5I_Ys052x3PT1USG6hgxM5HqyYOZrtSLi4A_niWpyXL5_Oa_9YLdk0HVVCzEAdvbrLf-JQZwm-JV0NJ_FERGxA priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKERIXxLuBggxC4oACseO1kwNCpaIqoHIAKvVmTRynXWk3KZtdwf4dfikzTrJtRMWJQy7rsSLPw57ZeL6PsRc5ek0pIYudTHWsQKg4h8TH6Cp4HibSAVBz8tEXfXisPp1MTrbYQHfUK7C9srQjPqnjxez1rx_rdxjwb0PAZ_pNi3uspqu0gh49ic01dh1PJkOBeqQuvioYrMaGxpkr540Op4Dh__dOfemoGl-jvHQuHdxmt_qEku91HnCHbfn6LrvRUUyu77Hf-xtE5q7hkjcVrxrMVedrN605VtuUQaLpOdQlnw9sudxfUMeueaAk4o6-TaB2_Dwepi3555kv2indoeLntV-h4BQ8bwP1RMupe4Uvfzacrh5MYbHmZz1RScvx7YG9-z47Pvjwff8w7nkZYoflxzLOC4lpB3EBOg8pqFxMIKtSXyqvccuoMOVC6yfaEfi6AiMBSii0cIVWhSld-oBt103tdxjH4lw4J6WoMJUz0gNoD9RMOwFdaiMjJgaDWNeDltMCZjYUL5m2nREtGtAGI1oTsVebOecdZMc_pd-TnTeSBLcdfmgWp7aPXlsZWbjSCD9xSqm8BIL0EXmZucQDLj9iz8lLLAFq1HRj5xRWbWs_fvtq9zABSkMWFbGXvVDV4Boc9A0QqAnC4BpJ7o4kMeLdeHhwRjsEjEWlKWm0TlBnzzbDNJM8oPbNKsiILCeI_og97Hx3s276qyLD8IyYGXn1SDHjkXp6FvDIsyQ1WS4f_Q9NPmY3ZQhIFQuxy7aXi5V_gmnfsngaYvkPecRXGw priority: 102 providerName: Scholars Portal |
Title | Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33838639 https://www.proquest.com/docview/2514276602 https://www.proquest.com/docview/2511894263 https://pubmed.ncbi.nlm.nih.gov/PMC8037892 https://doaj.org/article/f72bcd71e5c4449da949919d8c0ea915 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwELdgCIkXxH_CRmUQEg8oWuK4dvK4TpsGaBMqTKp4sS6OwyqtSbW0mvp1-KTcOUlphAQvPDQP9VmJ787nu-Tud4y9y1BrCgFpaEWiQgmxDDOIXIiqgudhJCwAFSefX6izS_lpNp7ttPqinLAWHrhl3GGpRW4LHbuxlVJmBRCaSpwVqY0cZL68XOCZ1wdT3fcDjXFXXyKTqsMGrbCiZNuYfmoc6sEx5NH6_7TJO4fSMGFy5wQ6fcQedq4jP2of-TG746on7H7bTHLzlP083mIvt6WVvC55WaNXutjYecUxriZfEYXMoSr4ou-Ly93vJrEb7psPcUtfIZZoBhdhP23FP1-7vJlTthRfVm6NhHNwvPFNJhpOdSp8dVtzSjKYw82GX3UtSRqOd_d9up-xy9OTb8dnYdeBIbQYaKzCLBfoYFDXP-sgAYn8hrRMXCGdQuNQonOFco6UJZh1CVoAFJCr2OZK5rqwyXO2V9WVe8k4huGxtULEJTptWjgA5YDKZsegCqVFwOJeIMZ28OS0gGvjw5RUmVaIBgVovBCNDtiH7ZxlC87xV-oJyXlLScDa_g9UN9Opm_mXugXsLWmJIeiMinJzfsC6aczHr1NzhK5O4v2lgL3viMoa12ChK3VAThDa1oDyYECJe9sOh3tlNJ1taQwyTQqtVIQ8e7MdppmkAZWr154mTjMC4w_Yi1Z3t-umlxIpbsSA6YFWDxgzHKnmVx55PI0SnWbi1f_g5D57IPyGlGEcH7C91c3avUYHb5WP2F090yN2b3Jy8WU68jsbr-cyxet08v0X3LxT9Q |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJwQviP8EBhgE4gFFix3XSR4Q2samlm4TGpu0N-M4zlZpTUrTaurX4QPwGblzkm4R0t720Jf4nMa58_2J7-5HyIcEpCbjOvYND6UvNBN-ogPrg6iAPQy40RqLkw8O5eBEfD_tn66Rv20tDKZVtjrRKeqsNPiNfBPssOCRlAH_Ov3tI2oUnq62EBq1WIzs8hJCturL8Bvw9yPne7vHOwO_QRXwDTjPcz9JORhNRLIzVodaJKyv4zy0mbASBD4HhwGePZAGW4cLHXGtM51KZlIp0igzIdz3DlkXIYQyPbK-vXv442h1bhFBvNeW5sRyswLtLzHJl-FP9v2oY_4cSsD_tuCaMewmal6zfHsPyYPGZaVbtYw9Imu2eEzu1iCWyyfkz86q53Nd0knLnOYleMOTpRkXFOJ59FFBuKguMjpp8XipvQKnXVIHekQNnn5MQf1O_HbanI4ubFqNMUuLTgu7AMKxtrRy4BYVxfoYOr8sKSY3jPVsSc8bKJSKwr87fPCn5ORWePSM9IqysC8IhfCfGcM5y8FZjLjVWlqN5bp9LTMZcY-wliHKNG3RcQEXyoVHsVQ1ExUwUDkmqsgjn1dzpnVTkBupt5HPK0ps6O0ulLMz1egHlUc8NVnEbN8IIZJMY9MglmSxCayG5XvkPUqJwpYdBeYEnelFVanhzyO1BS5W6Pw0j3xqiPIS1mB0U2IBbwK7fHUoNzqUoFNMd7gVRtXotEpd7UCPvFsN40yUgMKWC0fD4gRBADzyvJbd1brxY0gMCsAjUUeqOy-mO1KMz13H8zgIozjhL29-rLfk3uD4YF_tDw9Hr8h97rad8BnbIL35bGFfg_s4T980e5aSX7etJv4BtByEpw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+fosfomycin+resistance+and+molecular+epidemiology+among+carbapenem-resistant+Klebsiella+pneumoniae+strains+from+two+tertiary+hospitals+in+China&rft.jtitle=BMC+microbiology&rft.au=Haichen+Wang&rft.au=Changhang+Min&rft.au=Jun+Li&rft.au=Ting+Yu&rft.date=2021-04-11&rft.pub=BMC&rft.eissn=1471-2180&rft.volume=21&rft.issue=1&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1186%2Fs12866-021-02165-7&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_f72bcd71e5c4449da949919d8c0ea915 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2180&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2180&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2180&client=summon |